EMA Unveils Revamped Human Medicines Unit

Old Hands To Head Up New Task Forces

Europe’s top drugs regulator has reorganized its operations to tackle what it calls “fundamental changes” brought by new legislative initiatives, digital technologies, global trends in science, and staff losses due to Brexit. More changes are to be implemented during the course of 2020 in a bid to optimize the agency’s regulatory and scientific output.

Keyboard_Adapt — The EMA is taking steps to meet future challenges • Source: Shutterstock

The European Medicines Agency has implemented its new organizational structure, including a fully integrated human medicines division, a move that was first announced at the end of last year as part of a “future-proofing” exercise that the agency hopes will keep up the quality of its services to stakeholders.

Spurred by the loss of staff following its relocation to Amsterdam, as well as the need to tackle new challenges...